We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+50.65%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$5.42B
AUM Growth
+$1.85B
(+52%)
Cap. Flow
+$509M
Cap. Flow
% of AUM
9.4%
Top 10 Holdings %
Top 10 Hldgs %
46.89%
Holding
89
New
20
Increased
11
Reduced
36
Closed
9
Top Buys
| 1 |
ADC Therapeutics
ADCT
|
+$210M |
| 2 |
BioNTech
BNTX
|
+$145M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$102M |
| 4 |
Pliant Therapeutics
PLRX
|
+$90.5M |
| 5 |
RPTX
Repare Therapeutics
RPTX
|
+$76.6M |
Top Sells
| 1 |
Biogen
BIIB
|
+$128M |
| 2 |
uniQure
QURE
|
+$90.1M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$75.7M |
| 4 |
Tandem Diabetes Care
TNDM
|
+$56.7M |
| 5 |
Centene
CNC
|
+$49M |
Sector Composition
| 1 | Healthcare | 93.05% |
| 2 | Industrials | 1.02% |
| 3 | Financials | 0.23% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRAH
51
DELISTED
PRA Health Sciences, Inc.
PRAH
| $27.2M | 0.5% |
279,336
-163,364
| -37% | -$15.2M |
|
|
TCRR
52
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $27.1M | 0.5% |
1,765,188
-2,100
| -0.1% | -$24.2K |
|
|
ODT
53
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $26.8M | 0.49% |
633,038
-75,000
| -11% | -$2.43M |
|
54
Twist Bioscience
TWST
$5.77B
| $26.7M | 0.49% |
589,300
-900
| -0.2% | -$32.3K |
|
55
Celldex Therapeutics
CLDX
$3.01B
| $26M | 0.48% |
+2,000,000
| New | +$8.86M |
|
56
Ardelyx
ARDX
$1.31B
| $24.3M | 0.45% |
3,514,100
-390,000
| -10% | -$2.71M |
|
57
Guardant Health
GH
$21.6B
| $24.1M | 0.45% |
+297,619
| New | +$24M |
|
|
HOOK
58
DELISTED
HOOKIPA Pharma
HOOK
| $21.6M | 0.4% |
186,061
-190
| -0.1% | -$18.5K |
|
|
BCEL
59
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $21.1M | 0.39% |
992,068
-136,738
| -12% | -$2.42M |
|
|
GRTS
60
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $20.4M | 0.38% |
3,064,994
-3,200
| -0.1% | -$21.6K |
|
61
Cabaletta Bio
CABA
$452M
| $15.9M | 0.29% |
1,425,896
| – | – |
|
62
Immunovant
IMVT
$8.19B
| $14.6M | 0.27% |
+600,000
| New | +$12.9M |
|
63
Stereotaxis
STXS
$161M
| $13.8M | 0.26% |
3,103,327
| – | – |
|
|
NVTA
64
DELISTED
Invitae Corporation
NVTA
| $13.1M | 0.24% |
+431,100
| New | +$7.52M |
|
65
SelectQuote
SLQT
$132M
| $12.6M | 0.23% |
+496,872
| New | +$13.3M |
|
|
ITMR
66
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $11.6M | 0.21% |
625,000
| – | – |
|
|
AKRO
67
DELISTED
Akero Therapeutics
AKRO
| $9.77M | 0.18% |
392,152
-177,361
| -31% | -$4.05M |
|
68
Royalty Pharma
RPRX
$25B
| $9.71M | 0.18% |
+200,000
| New | +$9.9M |
|
|
BMY.RT
69
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $8.83M | 0.16% |
2,467,000
+78,000
| +3% | +$281K |
|
|
PROF
70
Profound Medical
PROF
$253M
| $6.78M | 0.13% |
400,000
| – | – |
|
|
AYLA
71
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
| $6.69M | 0.12% |
+666,666
| New | +$9.26M |
|
72
Xeris Biopharma Holdings
XERS
$1.5B
| $6.38M | 0.12% |
2,397,441
-560,000
| -19% | -$1.95M |
|
|
CBAY
73
DELISTED
Cymabay Therapeutics
CBAY
| $5.84M | 0.11% |
1,674,447
-1,076,169
| -39% | -$3.11M |
|
74
Wave Life Sciences
WVE
$1.14B
| $4.32M | 0.08% |
415,155
-2,512,197
| -86% | -$23.6M |
|
|
BNR
75
Burning Rock Biotech
BNR
$98.1M
| $3.62M | 0.07% |
+13,393
| New | +$3.67M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO